Children at Risk of Multidrug-Resistant TB Get Prevention Option

resisttb
Jan 5
1 min read

The results of the TB-CHAMP trial were recently published. They showed that prophylactic levofloxacin can significantly reduce the risk of contracting MDR-TB in children younger than 5 who had a household exposure. This is one of the first successful trials for prevention of MDR-TB. Read more here.

Recent Posts

See All

International Course on the Clinical and Programmatic Management of DRTB

In person in Taipei in October 2025, by Prof Chen-Yuan Chiang. This course is essential for staff from National TB Programmes in charge...

USAid cuts could create untreatable TB bug ‘resistant to everything we have’

The Stop TB Partnership has raised alarms for the potential for new TB mutations associated with interruptions in care. The COVID...

World Health Organization warns of possible tuberculosis surge because of USAID cuts

A recent statement from the WHO warned of a spike in tuberculosis as a result of the shuttering of USAID. This trend can already be seen...

Comments